{"database": "lobbying", "table": "lobbying_activities", "rows": [[2635678, "f61f83b1-c75c-4b20-8cec-bbd2d921a798", "Q2", "RIVENDELL GROUP LLP", 401103952, "GENENTECH", 2021, "second_quarter", "MMM", "Issues related to Medicare and Medicaid coverage and reimbursement, drug pricing,  the 340B Drug Discount Program, and issues related to the International Pricing Index for Medicare Part B and general reference pricing.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2021-07-12T22:56:23.767000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2635678"], "units": {}, "query_ms": 7.3327780701220036, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}